Drugmakers brace for US political side effects
from Viewsroom Hosted by Reuters
Donald Trump’s health agency nominee, Robert Kennedy, brings dangerous views on vaccines as well as skepticism about sky-high medicine prices. In this week’s Viewsroom, Breakingviews columnists discuss the impact on giants like Novo Nordisk and how other countries might react. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Viewsroom?
This episode is 18 minutes long.
When was this Viewsroom episode published?
This episode was published on December 5, 2024.
Can I download this Viewsroom episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.